Vision rehabilitation and follow-up are important for patients with AMD and may improve vision-related quality of life.[4]American Academy of Ophthalmology. Age-related macular degeneration preferred practice pattern 2024. Feb 2025 [internet publication].
https://www.aao.org/education/preferred-practice-pattern/age-related-macular-degeneration-ppp
[39]National Institute for Health and Care Excellence. Age-related macular degeneration. Jan 2018 [internet publication].
https://www.nice.org.uk/guidance/ng82
[131]van Nispen RM, Virgili G, Hoeben M, et al. Low vision rehabilitation for better quality of life in visually impaired adults. Cochrane Database Syst Rev. 2020 Jan 27;1(1):CD006543.
https://pmc.ncbi.nlm.nih.gov/articles/PMC6984642
http://www.ncbi.nlm.nih.gov/pubmed/31985055?tool=bestpractice.com
Provide information about vision rehabilitation to patients with any degree of vision loss, because even early loss can be associated with disability. Vision rehabilitation should then be individualised to each patient and extend beyond medical therapies to improve other meaningful outcomes (e.g., reading, daily living activities, safety, community participation, and psychosocial well-being).[132]Jackson ML, Virgili G, Shepherd JD, et al. Vision rehabilitation preferred practice pattern®. Ophthalmology. 2023 Mar;130(3):P271-335.
https://www.aaojournal.org/article/S0161-6420(22)00869-7/fulltext
[133]Riley M. Looking but not seeing. BMJ. 2023 Sep 20;382:1702. Consider referral to consultant rehabilitation services where these are available. Remote, internet-based services may improve access to visual rehabilitation, but more evidence as to its efficacy compared with face-to-face services is needed.[134]Bittner AK, Yoshinaga PD, Rittiphairoj T, et al. Telerehabilitation for people with low vision. Cochrane Database Syst Rev. 2023 Jan 13;1(1):CD011019.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9837841
http://www.ncbi.nlm.nih.gov/pubmed/36637057?tool=bestpractice.com
Patients with AMD are encouraged to stop smoking; to eat a balanced diet that has a low glycaemic index and is rich in fruits, vegetables, and fish high in omega-3 fatty acids; and to modify cardiovascular risk factors (including lowering cholesterol and saturated fat intake and controlling hypertension).[35]Chiu CJ, Klein R, Milton RC, et al. Does eating particular diets alter the risk of age-related macular degeneration in users of the age-related eye disease study supplements? Br J Ophthalmol. 2009 Sep;93(9):1241-6.
http://www.ncbi.nlm.nih.gov/pubmed/19508997?tool=bestpractice.com
[135]Seddon JM, De D, Rosner B. The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis. Am J Clin Nutr. 2024 Dec;120(6):1387-98.
https://pmc.ncbi.nlm.nih.gov/articles/PMC11619796
http://www.ncbi.nlm.nih.gov/pubmed/39181206?tool=bestpractice.com
Adherence to a mediterranean diet, including lower consumption of red meat, has been associated with reduced risk of AMD progression.[17]Chapman NA, Jacobs RJ, Braakhuis AJ. Role of diet and food intake in age-related macular degeneration: a systematic review. Clin Exp Ophthalmol. 2019 Jan;47(1):106-27.
http://www.ncbi.nlm.nih.gov/pubmed/29927057?tool=bestpractice.com
[136]Agrón E, Mares J, Chew EY, et al. Adherence to a mediterranean diet and geographic atrophy enlargement rate: age-related eye disease study 2 report 29. Ophthalmol Retina. 2022 Sep;6(9):762-70.
https://pmc.ncbi.nlm.nih.gov/articles/PMC9464676
http://www.ncbi.nlm.nih.gov/pubmed/35381392?tool=bestpractice.com
However, supplementation with omega-3 long-chain polyunsaturated fatty acids does not influence the risk of progressing to late AMD.[55]Lawrenson JG, Evans JR. Omega 3 fatty acids for preventing or slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2015 Apr 9;2015(4):CD010015.
https://onlinelibrary.wiley.com/doi/10.1002/14651858.CD010015.pub3/full
http://www.ncbi.nlm.nih.gov/pubmed/25856365?tool=bestpractice.com
[
]
Can omega 3 fatty acids slow the progression of age-related macular degeneration?/cca.html?targetUrl=https://cochranelibrary.com/cca/doi/10.1002/cca.836/fullShow me the answer For appropriate patients, high-dose vitamin and mineral supplementation can be recommended (using the AREDS2 formulation from the Age-Related Eye Disease Study Group studies). Evidence from randomised controlled trials and one Cochrane review suggest that antioxidant vitamin and mineral supplementation may reduce the development of late AMD in patients with intermediate AMD, or progression in the less involved eye in patients with late AMD in one eye.[4]American Academy of Ophthalmology. Age-related macular degeneration preferred practice pattern 2024. Feb 2025 [internet publication].
https://www.aao.org/education/preferred-practice-pattern/age-related-macular-degeneration-ppp
[52]Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001 Oct;119(10):1417-36.
https://jamanetwork.com/journals/jamaophthalmology/fullarticle/268224
http://www.ncbi.nlm.nih.gov/pubmed/11594942?tool=bestpractice.com
[56]Age-Related Eye Disease Study 2 Research Group. Lutein plus zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013 May 15;309(19):2005-15.
https://jamanetwork.com/journals/jama/fullarticle/1684847
http://www.ncbi.nlm.nih.gov/pubmed/23644932?tool=bestpractice.com
[57]Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database Syst Rev. 2023 Sep 13;9(9):CD000254.
http://www.ncbi.nlm.nih.gov/pubmed/37702300?tool=bestpractice.com